NRP2 and colorectal carcinoma: The MET transition was also observed in subcutaneous tumors formed by Nrp2−/− CRC organoids, which was demonstrated by a significant reduction of EMT drivers, ZEB1, and SNAI2, and a mesenchymal marker, vimentin (Figure 2d).